Igf-1-riact (insuline Like Growth Hormone) (2017-10-24)

Recall Summary IGF-1-RIACT, an insulin-like growth hormone product, is being recalled across Canada due to issues classified as a Class I medical device concern. This recall affects all Canadian consumers who have this product. The specific nature of the device issue prompting the recall is not detailed in the provided information.

Reason
Medical devices
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DEVICES
Recall date
2017-11-10
Status
Closed
Distribution
Canada-wide

Official recall notice from HC-DEVICES

Recall details on Nibble Recalls: https://trynibble.app/recalls/e0e1b434-5506-45b7-b959-0dc1d6bb927b